vs
网件(NTGR)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是网件的1.1倍($197.9M vs $182.5M),REPLIGEN CORP同比增速更快(13.6% vs 0.0%),REPLIGEN CORP自由现金流更多($17.6M vs $13.6M),过去两年REPLIGEN CORP的营收复合增速更高(14.4% vs 5.3%)
网件是总部位于美国加利福尼亚州圣何塞的计算机网络设备企业,在全球约22个国家设有分支机构,面向个人消费者、企业及服务提供商研发生产各类网络硬件,业务分为零售、商业客户、服务供应商三大板块。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
NTGR vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.1倍
$182.5M
营收增速更快
RGEN
高出13.6%
0.0%
自由现金流更多
RGEN
多$3.9M
$13.6M
两年增速更快
RGEN
近两年复合增速
5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $182.5M | $197.9M |
| 净利润 | — | $13.3M |
| 毛利率 | 40.4% | 52.5% |
| 营业利润率 | -2.6% | 9.0% |
| 净利率 | — | 6.7% |
| 营收同比 | 0.0% | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益(稀释后) | $-0.03 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
NTGR
RGEN
| Q4 25 | $182.5M | $197.9M | ||
| Q3 25 | $184.6M | $188.8M | ||
| Q2 25 | $170.5M | $182.4M | ||
| Q1 25 | $162.1M | $169.2M | ||
| Q4 24 | $182.4M | $174.1M | ||
| Q3 24 | $182.9M | $154.9M | ||
| Q2 24 | $143.9M | $154.1M | ||
| Q1 24 | $164.6M | $151.3M |
净利润
NTGR
RGEN
| Q4 25 | — | $13.3M | ||
| Q3 25 | $-4.8M | $14.9M | ||
| Q2 25 | $-6.4M | $14.9M | ||
| Q1 25 | $-6.0M | $5.8M | ||
| Q4 24 | $-8.9M | $-30.3M | ||
| Q3 24 | $85.1M | $-654.0K | ||
| Q2 24 | $-45.2M | $3.3M | ||
| Q1 24 | $-18.6M | $2.1M |
毛利率
NTGR
RGEN
| Q4 25 | 40.4% | 52.5% | ||
| Q3 25 | 39.1% | 53.2% | ||
| Q2 25 | 37.5% | 50.0% | ||
| Q1 25 | 34.8% | 53.6% | ||
| Q4 24 | 32.6% | 26.1% | ||
| Q3 24 | 30.9% | 50.0% | ||
| Q2 24 | 22.1% | 49.8% | ||
| Q1 24 | 29.3% | 49.5% |
营业利润率
NTGR
RGEN
| Q4 25 | -2.6% | 9.0% | ||
| Q3 25 | -3.8% | 8.9% | ||
| Q2 25 | -5.6% | 7.6% | ||
| Q1 25 | -7.9% | 3.9% | ||
| Q4 24 | -8.3% | -17.7% | ||
| Q3 24 | 52.4% | -5.1% | ||
| Q2 24 | -32.6% | 1.0% | ||
| Q1 24 | -13.2% | 1.3% |
净利率
NTGR
RGEN
| Q4 25 | — | 6.7% | ||
| Q3 25 | -2.6% | 7.9% | ||
| Q2 25 | -3.8% | 8.2% | ||
| Q1 25 | -3.7% | 3.4% | ||
| Q4 24 | -4.9% | -17.4% | ||
| Q3 24 | 46.5% | -0.4% | ||
| Q2 24 | -31.4% | 2.2% | ||
| Q1 24 | -11.3% | 1.4% |
每股收益(稀释后)
NTGR
RGEN
| Q4 25 | $-0.03 | $0.24 | ||
| Q3 25 | $-0.17 | $0.26 | ||
| Q2 25 | $-0.22 | $0.26 | ||
| Q1 25 | $-0.21 | $0.10 | ||
| Q4 24 | $-0.29 | $-0.55 | ||
| Q3 24 | $2.90 | $-0.01 | ||
| Q2 24 | $-1.56 | $0.06 | ||
| Q1 24 | $-0.63 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $323.0M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $497.8M | $2.1B |
| 总资产 | $836.3M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
NTGR
RGEN
| Q4 25 | $323.0M | $767.6M | ||
| Q3 25 | $326.4M | $748.7M | ||
| Q2 25 | $363.5M | $708.9M | ||
| Q1 25 | $391.9M | $697.2M | ||
| Q4 24 | $408.7M | $757.4M | ||
| Q3 24 | $395.7M | $784.0M | ||
| Q2 24 | $294.3M | $809.1M | ||
| Q1 24 | $289.4M | $780.6M |
总债务
NTGR
RGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
NTGR
RGEN
| Q4 25 | $497.8M | $2.1B | ||
| Q3 25 | $506.8M | $2.1B | ||
| Q2 25 | $523.2M | $2.1B | ||
| Q1 25 | $534.2M | $2.0B | ||
| Q4 24 | $541.1M | $2.0B | ||
| Q3 24 | $550.3M | $2.0B | ||
| Q2 24 | $459.4M | $2.0B | ||
| Q1 24 | $511.4M | $2.0B |
总资产
NTGR
RGEN
| Q4 25 | $836.3M | $2.9B | ||
| Q3 25 | $810.8M | $2.9B | ||
| Q2 25 | $803.5M | $2.9B | ||
| Q1 25 | $814.2M | $2.9B | ||
| Q4 24 | $850.2M | $2.8B | ||
| Q3 24 | $862.6M | $2.8B | ||
| Q2 24 | $754.1M | $2.9B | ||
| Q1 24 | $801.3M | $2.8B |
负债/权益比
NTGR
RGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $19.5M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $13.6M | $17.6M |
| 自由现金流率自由现金流/营收 | 7.5% | 8.9% |
| 资本支出强度资本支出/营收 | 3.2% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-18.9M | $93.9M |
8季度趋势,按日历期对齐
经营现金流
NTGR
RGEN
| Q4 25 | $19.5M | $25.7M | ||
| Q3 25 | $-7.4M | $48.1M | ||
| Q2 25 | $-1.8M | $28.6M | ||
| Q1 25 | $-8.7M | $15.0M | ||
| Q4 24 | $21.5M | $39.2M | ||
| Q3 24 | $107.7M | $49.3M | ||
| Q2 24 | $18.4M | $42.2M | ||
| Q1 24 | $17.2M | $44.7M |
自由现金流
NTGR
RGEN
| Q4 25 | $13.6M | $17.6M | ||
| Q3 25 | $-17.1M | $43.4M | ||
| Q2 25 | $-5.3M | $21.5M | ||
| Q1 25 | $-10.1M | $11.4M | ||
| Q4 24 | $19.0M | $33.6M | ||
| Q3 24 | $106.0M | $42.3M | ||
| Q2 24 | $16.1M | $37.4M | ||
| Q1 24 | $14.7M | $36.4M |
自由现金流率
NTGR
RGEN
| Q4 25 | 7.5% | 8.9% | ||
| Q3 25 | -9.3% | 23.0% | ||
| Q2 25 | -3.1% | 11.8% | ||
| Q1 25 | -6.3% | 6.8% | ||
| Q4 24 | 10.4% | 19.3% | ||
| Q3 24 | 58.0% | 27.3% | ||
| Q2 24 | 11.2% | 24.3% | ||
| Q1 24 | 8.9% | 24.0% |
资本支出强度
NTGR
RGEN
| Q4 25 | 3.2% | 4.1% | ||
| Q3 25 | 5.3% | 2.5% | ||
| Q2 25 | 2.1% | 3.9% | ||
| Q1 25 | 0.9% | 2.1% | ||
| Q4 24 | 1.4% | 3.2% | ||
| Q3 24 | 0.9% | 4.5% | ||
| Q2 24 | 1.6% | 3.1% | ||
| Q1 24 | 1.5% | 5.5% |
现金转化率
NTGR
RGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NTGR
| Other | $93.4M | 51% |
| Sales Channel Directly To Consumer | $89.1M | 49% |
RGEN
暂无分部数据